LAURA COSENZA: Open Payments
NPI 1376852467 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $294 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $104 |
| Medtronic, Inc. | 1 | $39 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
Products named: MINIMED 780G, Ozempic, GVOKE HYPOPEN, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
